Merida Biosciences
Merida Biosciences is a biotechnology company developing precision therapeutics to eliminate disease-causing antibodies, particularly for autoimmune conditions like Graves' disease. Launched publicly in April 2025, it has raised $121M in Series A funding and employs 64 people.
The growth story
Merida Biosciences grew from 4 to 64 employees between 2023 and 2026, raising $121M along the way, most recently a Series A in April 2025.
About
Merida Biosciences creates therapies targeting pathogenic antibodies that drive autoimmune and allergic diseases. Its lead program focuses on Graves' disease, aiming to clear autoantibodies that attack the thyroid gland.
The company raised $121M in its Series A round in April 2025, backed by prominent investors including BVF Partners, Third Rock Ventures, and Google Ventures. With 64 employees, it is headquartered in Cambridge, MA, a hub for biotech innovation.
Founders and leadership
Merida's largest function is Research, with 17 employees. The company is led by a team with ties to major biotech firms and investors, reflecting its focus on precision therapeutics. Its median tenure of 1 year suggests a relatively new and growing organization.
The Merida Biosciences org chart
Adam Townsend (Chief Executive Officer) leads 35 mapped leaders with 3 direct reports. Click +N to expand a team; names link to the person’s public profile.
Departments, and which ones grew
Headcount by function: Research 25 (+25% YoY), Business Development 10 (+43% YoY), Operations 5 (+25% YoY), Human Resources 4 (+33% YoY), Finance 3 (0% YoY).
Talent flow
Merida draws heavily from Biogen, Third Rock Ventures, and Dragonfly Therapeutics, with 8, 7, and 6 hires respectively. Alumni have moved to roles at Alera Bio, Korsana Biosciences, and IND Bioconsulting, among others.
Most common previous employers of Merida Biosciences staff: Biogen (8), Third Rock Ventures (7), Dragonfly Therapeutics (6), Sanofi (5), TCR2 (4), Scholar Rock (4). Former Merida Biosciences employees most often moved to Alera Bio (1), Northeastern University (1), ClearView Healthcare Partners (1), Korsana Biosciences (1), IND Bioconsulting (IBC) (1), Tutor (1).
Hiring now
Web traffic
Traffic mix: 0% direct, 0% search, 0% social, 0% paid.
What this company is made of
Most common skills at Merida Biosciences: Research Skills (20), Biotechnology (20), Microsoft Office (19), Cell Culture (18), ELISA (16), Data Analysis (15), Molecular Biology (15), Biochemistry (15).
Where the team actually sits
Merida Biosciences people are concentrated in Massachusetts, United States (25), Greater Boston (18), United States (5), Raleigh-Durham-Chapel Hill Area (1).
Search footprint
Merida Biosciences attracts about 35 organic search visits a month, traffic worth roughly $0K a month if bought through ads. It gained 6 ranking keywords and lost 4 in the last period.
Frequently asked
Merida Biosciences has 64 employees as of September 2026.
Merida Biosciences has raised $121M in total, most recently a Series A round in April 2025.
Adam Townsend (Chief Executive Officer) sits at the top of Merida Biosciences's reporting structure, with 3 direct reports.
The most common previous employers of current Merida Biosciences staff are Biogen (8 people), Third Rock Ventures (7 people), Dragonfly Therapeutics (6 people).
Former Merida Biosciences employees most often move to Alera Bio (1), Northeastern University (1), ClearView Healthcare Partners (1).
Merida Biosciences attracts about 35 organic search visits a month, worth roughly $0K a month in equivalent ad spend.
The most common skills among Merida Biosciences staff are Research Skills, Biotechnology, Microsoft Office, Cell Culture, ELISA.
Merida Biosciences staff are concentrated in Massachusetts, United States (25), Greater Boston (18), United States (5).
Merida Biosciences has about 25 people in Research, up 25% over the past year, as of September 2026.
Merida Biosciences has about 10 people in Business Development, up 43% over the past year, as of September 2026.
Computed from 53 current and 9 former Merida Biosciences profiles, as of September 2026. Source: Crustdata.
Build this for any company
Every number on this page came from the Crustdata API. Point the MCP at a company and get the same org chart, alumni list and talent flow in one prompt.